Skip to main content
Myeloablative chemoradiotherapy versus continued chemotherapy for high risk neuroblastoma.
Comparison of autologous and allogeneic bone marrow transplantation for neuroblastoma.
Response of neuroblastoma to retinoic acid in vitro and in vivo.
Intensive chemoradiotherapy and autologous bone marrow transplantation for poor prognosis neuroblastoma.
Butyrate analogues modulate globin gene expression in human and ovine erythroid cells.
Hormones and receptors in developing lung.